India, Aug. 17 -- The following biotech stocks reached 52-week highs on August 14, 2026, following positive quarterly reports or an announced upcoming acquisition.
Eton Pharmaceuticals Inc. (ETON)
Eton Pharmaceuticals specializes in the development and commercialization of therapies for rare diseases. Following a rise of over 44% in intraday trading, shares touched a 52-week high of $59.79.
In the second quarter of this year, Eton saw a 99% year-over-year growth in net product sales, and turned a profit of $11.6 million, compared to $2.6 million in the previous year.
The company markets KHINDIVI, INCRELEX, ALKINDI SPRINKLE, GALZIN, and HEMANGEOL; and has four more additional product candidates in late-stage development. The drug DESMODA...